FDA Plans Rare Advisory Hearing to Debate Moderna’s Flu Shot
Moderna, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $47.19
-0.8% in 1d after detection
Post-detection moves
1h
—
1d
-0.8%
3d
+0.7%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS